Quantitative Subharmonic Breast Imaging

PHASE4CompletedINTERVENTIONAL
Enrollment

219

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

April 5, 2019

Study Completion Date

April 5, 2019

Conditions
Breast Cancer
Interventions
DRUG

3D HI and SHI of UCA

Perflutren injection, suspension (IV)0.25 ml followed by 3D Harmonic imaging (HI) then (IV) 20 micro-l/kg followed by 3D subharmonic imaging (SHI)

Trial Locations (2)

19107

Thomas Jefferson University, Dept of Radiology, Philadelphia

92093

University of California, San Diego, La Jolla

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Lantheus Medical Imaging

INDUSTRY

collaborator

University of California, San Diego

OTHER

lead

Thomas Jefferson University

OTHER